Search research articles
Contact Us
Filters
Showing results (61-70 of 102) with videos related to
Page
of 11
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 21, 2016
Genome-Wide Association Study for Anthracycline-Induced Congestive Heart Failure
Bryan P Schneider, Fei Shen, Laura Gardner, et al.
JCO Oncology Advances
|
May 7, 2025
Multiomic Characterization of <i>RCC1</i> and <i>RCC2</i> Expression and Their Association With Molecular Alterations, Immune Phenotypes, and Cancer Outcomes
Misako Nagasaka, Brian Warnecke, Sai-Hong Ignatius Ou, et al.
Journal of the National Cancer Institute
|
January 2, 2017
Role of RPL39 in Metaplastic Breast Cancer
Bhuvanesh Dave, Daniel D Gonzalez, Zhi-Bin Liu, et al.
Nature Communications
|
October 24, 2018
Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II
Yujing Li, Yunhua Liu, Hanchen Xu, et al.
JCO Precision Oncology
|
April 28, 2025
Association of Androgen Receptor Expression With Tumor Immune Landscape and Treatment Outcomes of Patients With Breast Cancer
Priya Jayachandran, Sachin K Deshmukh, Sharon Wu, et al.
Nature Communications
|
July 7, 2026
Retraction Note: Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II
Yujing Li, Yunhua Liu, Hanchen Xu, et al.
Cancer Research Communications
|
July 31, 2025
GPSai: A Clinically Validated AI Tool for Tissue of Origin Prediction during Routine Tumor Profiling
Hassan Ghani, Anthony Helmstetter, Jennifer R Ribeiro, et al.
Oncogene
|
March 9, 2021
Correction: The nuclear hypoxia-regulated NLUCAT1 long non-coding RNA contributes to an aggressive phenotype in lung adenocarcinoma through regulation of oxidative stress
Laura Moreno Leon, Marine Gautier, Richard Allan, et al.
Oncogene
|
August 17, 2019
The nuclear hypoxia-regulated NLUCAT1 long non-coding RNA contributes to an aggressive phenotype in lung adenocarcinoma through regulation of oxidative stress
Laura Moreno Leon, Marine Gautier, Richard Allan, et al.
JCO Precision Oncology
|
January 21, 2026
HER2 Protein Overexpression, mRNA Expression, and DNA Amplification Across Solid Tumors: Comparison of Next-Generation Sequencing-Based Assays With Immunohistochemistry
Michiko Nagamine, Takao Fujisawa, Naoya Sakamoto, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 102) with videos related to
Sort By:
Page
of 11
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 21, 2016
Genome-Wide Association Study for Anthracycline-Induced Congestive Heart Failure
Bryan P Schneider, Fei Shen, Laura Gardner, et al.
JCO Oncology Advances
|
May 7, 2025
Multiomic Characterization of <i>RCC1</i> and <i>RCC2</i> Expression and Their Association With Molecular Alterations, Immune Phenotypes, and Cancer Outcomes
Misako Nagasaka, Brian Warnecke, Sai-Hong Ignatius Ou, et al.
Journal of the National Cancer Institute
|
January 2, 2017
Role of RPL39 in Metaplastic Breast Cancer
Bhuvanesh Dave, Daniel D Gonzalez, Zhi-Bin Liu, et al.
Nature Communications
|
October 24, 2018
Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II
Yujing Li, Yunhua Liu, Hanchen Xu, et al.
JCO Precision Oncology
|
April 28, 2025
Association of Androgen Receptor Expression With Tumor Immune Landscape and Treatment Outcomes of Patients With Breast Cancer
Priya Jayachandran, Sachin K Deshmukh, Sharon Wu, et al.
Nature Communications
|
July 7, 2026
Retraction Note: Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II
Yujing Li, Yunhua Liu, Hanchen Xu, et al.
Cancer Research Communications
|
July 31, 2025
GPSai: A Clinically Validated AI Tool for Tissue of Origin Prediction during Routine Tumor Profiling
Hassan Ghani, Anthony Helmstetter, Jennifer R Ribeiro, et al.
Oncogene
|
March 9, 2021
Correction: The nuclear hypoxia-regulated NLUCAT1 long non-coding RNA contributes to an aggressive phenotype in lung adenocarcinoma through regulation of oxidative stress
Laura Moreno Leon, Marine Gautier, Richard Allan, et al.
Oncogene
|
August 17, 2019
The nuclear hypoxia-regulated NLUCAT1 long non-coding RNA contributes to an aggressive phenotype in lung adenocarcinoma through regulation of oxidative stress
Laura Moreno Leon, Marine Gautier, Richard Allan, et al.
JCO Precision Oncology
|
January 21, 2026
HER2 Protein Overexpression, mRNA Expression, and DNA Amplification Across Solid Tumors: Comparison of Next-Generation Sequencing-Based Assays With Immunohistochemistry
Michiko Nagamine, Takao Fujisawa, Naoya Sakamoto, et al.
Page
of 11